Study about long-term benefits for heart of some medicines

Taking GLP-1 medicines that mimic the action of glucagon a hormone that helps control blood glucose levels (for diabetics, but usually improperly used for weight loss) reduces the risk of heart attacks; however researchers warn that if they are stopped these benefits diminish more quickly than the time needed with therapy to improve the patient's heart health. One study suggests that for example if the drugs are taken for three years obtaining cardiovascular benefits in this way, then stopping the therapy within a year and a half causes these benefits to be lost. Nausea, fatigue and the cost of these medicines are the reasons why people usually tend not to continue the therapy, but this could have consequences for the cardiovascular system; therefore the situation regarding heart health should be appropriately monitored.

Posta elettronica:       info@salutary.eu
Tel:   +39 338 1809310        Data:    19/03/2026              n°:   6208      

---